OncoSec

YTD

ALL

Why Robinhood?

You can watch OncoSec and buy or sell other stocks, ETFs, and their options commission-free!

About ONCS

OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor.

CEO

Robert H. Arch, PhD

CEORobert H. Arch, PhD

Employees

—

Employees—

Headquarters

Ewing, New Jersey

HeadquartersEwing, New Jersey

Founded

2008

Founded2008

Employees

—

Employees—

ONCS Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

433.33

Average volume433.33

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.0001

52 Week high$0.0001

52 Week low

—

52 Week low—

Stock Snapshot

OncoSec(ONCS) trades at $3.69.

During the trading day, OncoSec(ONCS) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for OncoSec(ONCS) stock has reached 0, versus its average volume of 433.33.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.